The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paharkova-Vatchkova, V.
Right arrow Articles by Kovats, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paharkova-Vatchkova, V.
Right arrow Articles by Kovats, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
Medline Plus Health Information
*Stem Cells
The Journal of Immunology, 2004, 172: 1426-1436.
Copyright © 2004 by The American Association of Immunologists

Estrogen Preferentially Promotes the Differentiation of CD11c+ CD11bintermediate Dendritic Cells from Bone Marrow Precursors1

Vladislava Paharkova-Vatchkova, Ruben Maldonado and Susan Kovats2

Division of Immunology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010

Sex biases in autoimmunity and infection suggest that steroid sex hormones directly modulate immune cells. We show in this study that 17-{beta}-estradiol (E2) promotes the differentiation of functional dendritic cells (DC) from murine bone marrow precursor cells. Remarkably, ex vivo DC differentiation was inhibited in steroid hormone-deficient medium, and was restored by addition of physiological amounts of E2, but not dihydrotestosterone. DC differentiation was inhibited by the estrogen receptor (ER) antagonists ICI 182,780 and tamoxifen, and from ER{alpha}-/- bone marrow cells, indicating that E2 acted via ERs. E2 addition was most effective in promoting DC differentiation immediately ex vivo, but did not increase DC proliferation. E2 treatment specifically promoted differentiation of a CD11c+ CD11bint DC population that displayed high levels of cell surface MHC class II and CD86, suggesting that E2 could augment numbers of potent APC. DC that differentiated in E2-supplemented medium were fully functional in their capability to mediate presentation of self and foreign Ags and stimulate the proliferation of naive CD4+ T cells. The requirement for estrogen during DC differentiation suggests a mechanism by which E2 levels in peripheral tissues might modulate both the number and functional capabilities of DC in vivo, thereby influencing immune responses.


Related articles in The JI:

IN THIS ISSUE

The JI 2004 172: 1331-1332. [Full Text]  



This article has been cited by other articles:


Home page
 BloodHome page
M. M. Escribese, T. Kraus, E. Rhee, A. Fernandez-Sesma, C. B. Lopez, and T. M. Moran
Estrogen inhibits dendritic cell maturation to RNA viruses
Blood, December 1, 2008; 112(12): 4574 - 4584.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
A. Maccio, C. Madeddu, E. Sanna, F. Panzone, A. Volpe, and G. Mantovani
Evidence that Human Serum with High Levels of Estrogens Interferes with Immune System Both by Decreasing CD25 Expression on T-Cell and by Increasing Interleukin-2 Availability
Reproductive Sciences, November 1, 2008; 15(9): 961 - 969.
[Abstract] [PDF]

Home page
 CVIHome page
X. Zhang, F. A. Castelli, X. Zhu, M. Wu, B. Maillere, and L. BenMohamed
Gender-Dependent HLA-DR-Restricted Epitopes Identified from Herpes Simplex Virus Type 1 Glycoprotein D
Clin. Vaccine Immunol., September 1, 2008; 15(9): 1436 - 1449.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Douin-Echinard, S. Laffont, C. Seillet, L. Delpy, A. Krust, P. Chambon, P. Gourdy, J.-F. Arnal, and J.-C. Guery
Estrogen Receptor {alpha}, but Not {beta}, Is Required for Optimal Dendritic Cell Differentiation and CD40-Induced Cytokine Production
J. Immunol., March 15, 2008; 180(6): 3661 - 3669.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. C. Siracusa, M. G. Overstreet, F. Housseau, A. L. Scott, and S. L. Klein
17{beta}-Estradiol Alters the Activity of Conventional and IFN-Producing Killer Dendritic Cells
J. Immunol., February 1, 2008; 180(3): 1423 - 1431.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Carreras, S. Turner, V. Paharkova-Vatchkova, A. Mao, C. Dascher, and S. Kovats
Estradiol Acts Directly on Bone Marrow Myeloid Progenitors to Differentially Regulate GM-CSF or Flt3 Ligand-Mediated Dendritic Cell Differentiation
J. Immunol., January 15, 2008; 180(2): 727 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
M. Ivanga, Y. Labrie, E. Calvo, P. Belleau, C. Martel, V. Luu-The, J. Morissette, F. Labrie, and F. Durocher
Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus
Physiol Genomics, March 14, 2007; 29(1): 13 - 23.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. K. Marriott, K. R. McGann-Gramling, B. Hauss-Wegrzyniak, L. C. Sheldahl, R. A. Shapiro, D. M. Dorsa, and G. L. Wenk
Brain Infusion of Lipopolysaccharide Increases Uterine Growth as a Function of Estrogen Replacement Regimen: Suppression of Uterine Estrogen Receptor-{alpha} by Constant, But Not Pulsed, Estrogen Replacement
Endocrinology, January 1, 2007; 148(1): 232 - 240.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. C. Harman, J. P. Miller, N. Nikbakht, R. Gerstein, and D. Allman
Mouse plasmacytoid dendritic cells derive exclusively from estrogen-resistant myeloid progenitors
Blood, August 1, 2006; 108(3): 878 - 885.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Verthelyi
Female's Heightened Immune Status: Estrogen, T Cells, and Inducible Nitric Oxide Synthase in the Balance
Endocrinology, February 1, 2006; 147(2): 659 - 661.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
K. C. Lambert, E. M. Curran, B. M. Judy, G. N. Milligan, D. B. Lubahn, and D. M. Estes
Estrogen Receptor {alpha} (ER{alpha}) Deficiency in Macrophages Results in Increased Stimulation of CD4+ T Cells while 17{beta}-Estradiol Acts through ER{alpha} to Increase IL-4 and GATA-3 Expression in CD4+ T Cells Independent of Antigen Presentation
J. Immunol., November 1, 2005; 175(9): 5716 - 5723.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Delpy, V. Douin-Echinard, L. Garidou, C. Bruand, A. Saoudi, and J.-C. Guery
Estrogen Enhances Susceptibility to Experimental Autoimmune Myasthenia Gravis by Promoting Type 1-Polarized Immune Responses
J. Immunol., October 15, 2005; 175(8): 5050 - 5057.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Mao, V. Paharkova-Vatchkova, J. Hardy, M. M. Miller, and S. Kovats
Estrogen Selectively Promotes the Differentiation of Dendritic Cells with Characteristics of Langerhans Cells
J. Immunol., October 15, 2005; 175(8): 5146 - 5151.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Nalbandian, V. Paharkova-Vatchkova, A. Mao, S. Nale, and S. Kovats
The Selective Estrogen Receptor Modulators, Tamoxifen and Raloxifene, Impair Dendritic Cell Differentiation and Activation
J. Immunol., August 15, 2005; 175(4): 2666 - 2675.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Garidou, S. Laffont, V. Douin-Echinard, C. Coureau, A. Krust, P. Chambon, and J.-C. Guery
Estrogen Receptor {alpha} Signaling in Inflammatory Leukocytes Is Dispensable for 17{beta}-Estradiol-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis
J. Immunol., August 15, 2004; 173(4): 2435 - 2442.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.